Hematological toxicity evaluation
HT
ADVERSE EVENT
Routine blood investigations were regularly performed for all patients. Complete blood counts including white blood cell (WBC), neutrophil (NEU), hemoglobin (HGB) and platelet (PLT) were determined at the time of diagnosis and weekly during neoadjuvant therapy and pre-operative evaluation. Instances of HT were graded according to the Common Terminology Criteria for Adverse Events v5.0 (CTCAE v5.0).